libp-rec
Vaccineexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Nov 4, 2022 (NCT05599516)
Timeline
2020s
- Jan 1, 2022
Earliest Phase 3 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05599516 | Phase 3 | Nov 4, 2022 | Beijing Tiantan Bio Co., Ltd, China National Biotec Group Co., Ltd, National Vaccine and Serum Institute, China |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Beijing Tiantan Bio Co., Ltd | For profit | 1 | 0 | 1 | 2022 |
| China National Biotec Group Co., Ltd | For profit | 1 | 0 | 1 | 2022 |
| National Vaccine and Serum Institute, China | For profit | 1 | 1 | 1 | 2022 |
3 organizations
Page 1 / 1